These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 38590052

  • 1. Health impact and cost-effectiveness of expanding routine immunization coverage in India through Intensified Mission Indradhanush.
    Clarke-Deelder E, Suharlim C, Chatterjee S, Portnoy A, Brenzel L, Ray A, Cohen JL, Menzies NA, Resch SC.
    Health Policy Plan; 2024 Jun 03; 39(6):583-592. PubMed ID: 38590052
    [Abstract] [Full Text] [Related]

  • 2. Impact of campaign-style delivery of routine vaccines: a quasi-experimental evaluation using routine health services data in India.
    Clarke-Deelder E, Suharlim C, Chatterjee S, Brenzel L, Ray A, Cohen JL, McConnell M, Resch SC, Menzies NA.
    Health Policy Plan; 2021 May 17; 36(4):454-463. PubMed ID: 33734362
    [Abstract] [Full Text] [Related]

  • 3. The incremental cost of improving immunization coverage in India through the Intensified Mission Indradhanush programme.
    Chatterjee S, Das P, Pinheiro A, Haldar P, Ray A, Brenzel L, Resch S.
    Health Policy Plan; 2021 Sep 09; 36(8):1316-1324. PubMed ID: 33950262
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
    Gupta M, Prinja S, Kumar R, Kaur M.
    Health Policy Plan; 2013 Jan 09; 28(1):51-61. PubMed ID: 22407018
    [Abstract] [Full Text] [Related]

  • 5. Improving vaccination coverage and timeliness through periodic intensification of routine immunization: evidence from Mission Indradhanush.
    Summan A, Nandi A, Deo S, Laxminarayan R.
    Ann N Y Acad Sci; 2021 Oct 09; 1502(1):110-120. PubMed ID: 34263929
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
    Vučina VV, Filipović SK, Kožnjak N, Stamenić V, Clark AD, Mounaud B, Blau J, Hoestlandt C, Kaić B.
    Vaccine; 2015 May 07; 33 Suppl 1():A209-18. PubMed ID: 25919163
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
    Russell LB, Kim SY, Cosgriff B, Pentakota SR, Schrag SJ, Sobanjo-Ter Meulen A, Verani JR, Sinha A.
    Vaccine; 2017 Dec 14; 35(49 Pt B):6905-6914. PubMed ID: 29129451
    [Abstract] [Full Text] [Related]

  • 8. Impact and cost effectiveness of pneumococcal conjugate vaccine in India.
    Krishnamoorthy Y, Eliyas SK, Nair NP, Sakthivel M, Sarveswaran G, Chinnakali P.
    Vaccine; 2019 Jan 21; 37(4):623-630. PubMed ID: 30587430
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the Universal Immunization Programme and introduction of a rotavirus vaccine in India with IndiaSim.
    Megiddo I, Colson AR, Nandi A, Chatterjee S, Prinja S, Khera A, Laxminarayan R.
    Vaccine; 2014 Aug 11; 32 Suppl 1():A151-61. PubMed ID: 25091670
    [Abstract] [Full Text] [Related]

  • 10. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
    Patel HD, Roberts ET, Constenla DO.
    Vaccine; 2013 Dec 09; 31(51):6072-8. PubMed ID: 24176497
    [Abstract] [Full Text] [Related]

  • 11. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P.
    Vaccine; 2012 Apr 16; 30(18):2839-47. PubMed ID: 22387220
    [Abstract] [Full Text] [Related]

  • 12. Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies.
    Vodicka E, Zimmermann M, Lopez AL, Silva MW, Gorgolon L, Kohei T, Mooney J, Muhib F, Pecenka C, Marfin AA.
    Vaccine; 2020 Mar 17; 38(13):2833-2840. PubMed ID: 32085954
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
    Villanueva-Uy MET, Lam HY, Aldaba JG, Uy TMZ, Valverde HA, Silva MWT, Mooney J, Clark A, Pecenka C.
    Vaccine; 2021 Nov 26; 39(48):7091-7100. PubMed ID: 34753614
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C.
    Vaccine; 2015 May 07; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [Abstract] [Full Text] [Related]

  • 15. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Anwari P, Debellut F, Pecenka C, Parwiz SM, Clark A, Groman D, Safi N.
    Vaccine; 2018 Dec 14; 36(51):7769-7774. PubMed ID: 29107346
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A, Preza I, Simaku A, Nelaj E, Clark AD, Felix Garcia AG, Lara C, Hoestlandt C, Blau J, Bino S.
    Vaccine; 2015 May 07; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [Abstract] [Full Text] [Related]

  • 17. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    Anderson JD, Pecenka CJ, Bagamian KH, Rheingans RD.
    PLoS One; 2020 May 07; 15(5):e0232941. PubMed ID: 32469927
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.